Preview

Комплексные проблемы сердечно-сосудистых заболеваний

Расширенный поиск

ДОКАЗАТЕЛЬНАЯ БАЗА ПРИОРИТЕТНОЙ РОЛИ ПЕРВИЧНОГО ЧРЕСКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА В РЕВАСКУЛЯРИЗАЦИИ БОЛЬНЫХ ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ СЕГМЕНТА ST

https://doi.org/10.17802/2306-1278-2013-1-24-34

Полный текст:

Аннотация

Первичное чрескожное коронарное вмешательство (ЧКВ) обеспечивает лучшие результаты лечения инфаркта миокарда с подъемом сегмента ST (ИМпST). Чем раньше выполняется вмешательство, тем выше выживаемость больных. Тромболитическая терапия может быть эффективнее катетерной реперфузии при задержке выполнения первичного ЧКВ. Допустимый интервал «времени задержки, обусловленный первичным ЧКВ», позволяющий сохранять преимущество эндоваскулярного подхода, находится в пределах 60–120 мин, что в большинстве случаев является выполнимым. При прогнозируемом времени от первого медицинского контакта до раздувания баллона более 90–120 мин необходимо регулировать логистическую схему доставки больных в ЧКВ-центры и увеличить количество таких центров, работающих в режиме круглосуточно.

Об авторе

В. И. Ганюков
Федеральное государственное бюджетное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний» Сибирского отделения Российской академии медицинских наук, Кемерово
Россия


Список литературы

1. Бокерия Л. А., Гудкова Р. Г. Сердечно-сосудистая хирургия. М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН, 2010. С. 7.

2. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction / E. M. Antman [et al.] // J. Am. Coll. Cardiol. 2008. Vol. 51. P. 210–47.

3. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines / F. G. Kushner [et al.] // JACC. 2009. Vol. 54. P. 2209.

4. A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction / H. R. Andersen [et al.] // N. Engl. J. Med. 2003. Vol. 349. Р.733–742.

5. ACC/AHA guidelines forthe management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) / E. M. Antman [et al.] // J. Am. Coll. Cardiol. 2004. Vol. 44.

6. Acceptable reperfusion delay to prefer primary angioplasty over fi brin-specifi c thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fi t all / G. Tarantini [et al.] // Eur. Heart J. 2010. Vol. 31(6). P. 676–683.

7. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators / G. W. Stone [et al.] //J. Am. Coll. Cardiol. 1997. Vol. 29. P. 901–907.

8. Assessment of the Safety and Effi cacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT–PCI): randomised trial // Lancet. 2006. Vol. 367. P. 569–78.

9. Betriu A., Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. // Am. J. Cardiol. 2005. Vol. 95. P. 100–101.

10. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients // Eur. Heart J., 2006. Vol. 27. P. 779–788.

11. Braunwald E. Historical milestones in reperfusion therapy for myocardial infarction // Bates E. R. (ed.). Reperfusion therapy for acute myocardial infarction / E. R. Bates; Informa Healthcare USA Inc. New York, 2008. P. 1.

12. Cantor W. J., Fitchett D., Borgundvaag B. Routine Early Angioplasty after Fibrinolysis. for Acute Myocardial Infarction // N. Engl. J. Med. 2009. Vol. 360. P. 2705–2718.

13. Comparison of primary coronary angioplasty and TLT for AMI: a quantitative review / W. D. Weaver [et al.] // JAMA. 1997. Vol. 278. P. 2093.

14. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI) / Т. Danchin [et al.] // Circulation. 2008. Vol. 118. P. 268–276.

15. Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial / D. J. Cohen [et al.] // Circulation, 2001. Vol. 104. P. 3039–3045.

16. Determinants of improvement in epicardial fl ow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II / E. M. Antman [et al.] // Eur Heart J. 2002. Vol. 23. P. 928–933.

17. Early TLT in AMI : reappraisal golden hour / E. Boersma [et al.] // Lancet. 1996. Vol. 348. P. 771–775.

18. Effi cacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances Results of the NORDISTEMI (NORwegian study on District treatment of ST-Elevation Myocardial Infarction) / E. Bøhme [et al.] //J. Am. Coll. Cardiol. 2010. Vol. 55. P. 102–110.

19. ESC Guidelines for the management of acut myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology / H. G. Steg [et al.] // Eur. Heart J. 2012. Vol. 33(20). P. 2569–2619.

20. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial / S. G. Ellis [et al.] //Am Heart J. 2004. Vol. 147. P. 16.

21. Frequent reocclusion of patent IRA between 4 weeks and 1 year / H.D. White [et al.] // JACC. 1995. Vol. 25. P. 218.

22. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) / W. Wijns [et al.] // Eur. Heart J. 2010. Vol. 31(20). P. 2501–2555.

23. Guidelines: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology / F. Van de Werf [et al.] // Eur. Heart J. 2008. Vol. 29(23). P. 2909–2945.

24. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy/ D. S. Pinto [et al.] // Circulation. 2006. Vol. 114. P. 2019–2025.

25. Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction Cost Analysis of the Canadian STAT Study / M. R. Le May [et al.] // Circulation. 2003. Vol. 108. P. 2624–2630.

26. How to set up an effective national primary angioplasty network: lessons learned from fi ve European countries / J. Knot [et al.] // EuroIntervention. 2009. Vol. 5(3). Р. 301–309.

27. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial / C. Di Mario [et al.] // Lancet. 2008. Vol. 371. P. 559–568.

28. Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: data from the CAPTIM randomized clinical trial / P. G. Steg [et al.] // Circulation, 2003. Vol. 108. P. 2851–2856.

29. Importance of IRA patency for recovery of LV function and late survival after PPCI / B. R. Brodie [et al.] //JACC, 1996. Vol. 28. P. 319.

30. Improvement in thtee-month angiographic outcome suggested after PCI for MI (Zwolle trial) compared with successful thrombolysis (APRICOT trial) / Veen G. [et al.] // Am J. Cardiol. 1999. Vol. 84. P. 793.

31. Keeley E. C., Boura J. A., Grines C. L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials // Lancet. 2006. Vol. 367. P. 579–588.

32. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial-PRAGUE-2 / P. Widimský [et al.] // Eur. Heart J. 2003. Vol. 24(1). P. 94–104.

33. Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction / U. Stenestrand [et al.] // JAMA. 2006. Vol. 296. P. 1749–1756.

34. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial / P. Widimsky [et al.] // Eur. Heart J. 2007. Vol. 28(6). P. 679–684.

35. Nallamothu B. K., Bates E. R. Percutaneous coronary intervention versus fi brinolytic therapy in acute myocardial infarction: is timing (almost) everything? // Am. J. Cardiol. 2003. Vol. 92. P. 824–826.

36. Optimal timing of coronary artery bypass graft surgery after acute myocardial infarctio / J. H. Braxton [et al.] // Circulation. 1995. Vol. 92 (II). P. 66–68.

37. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis-a pathological thrombectomy study in primary percutaneous coronary intervention / S. H. Rittersma [et al.] // Circulation. 2005. Vol. 11. P. 1160–1165.

38. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 23 randomized trials / E. C. Keeley [et al.] // Lancet. 2003. Vol. 361. P. 13–20.

39. Primary angioplasty versus prehospital fi brinolysis in acute myocardial infarction: a randomised study / E. Bonnefoy [et al.] // Lancet, 2002. Vol. 360. P. 825–829.

40. Primery angioplasty vs. Early routine post-fi brinolysis angioplasty for AMI with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial / F. Fernandez-Aviles [et al.] // Eur. Heart J. 2007. Vol. 28. P. 949–960.

41. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time / J. M. Juliard [et al.] // Am. J. Cardiol. 2003. Vol. 91. P. 1401–1405.

42. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries / P. Widimsky [et al.] // Eur. Heart J. 2010. Vol. 31(8). Р. 943–957.

43. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment levation (GRACIA-1) / F. Fernandez-Aviles [et al.] // Lancet. 2004. Vol. 364. P. 1045–1053.

44. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 / W. J. Rogers [et al.] // J. Am. Coll. Cardiol. 2000. Vol. 36. P. 2056–2063.

45. The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial. InfarctionThe GUSTO Angiographic Investigators // N. Engl. J. Med. 1993. Vol. 329. P. 1615–1622.

46. Widimsky P. Improving patient outcomes: networking and logistics are one of the future challenges. Presentation at 21st May 2009, PCR2009.

47. Widimsky P. Primary angioplasty vs. thrombolysis: the end of the controversy? // Eur. Heart J. 2010. Vol. 31(6). Р. 634–636.


Для цитирования:


Ганюков В.И. ДОКАЗАТЕЛЬНАЯ БАЗА ПРИОРИТЕТНОЙ РОЛИ ПЕРВИЧНОГО ЧРЕСКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА В РЕВАСКУЛЯРИЗАЦИИ БОЛЬНЫХ ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ СЕГМЕНТА ST. Комплексные проблемы сердечно-сосудистых заболеваний. 2013;(1):24-34. https://doi.org/10.17802/2306-1278-2013-1-24-34

For citation:


Ganyukov V.I. EVIDENCE BASE FOR PRIORITY ROLE OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN REVASCULARIZATION OF STEMI PATIENTS. Complex Issues of Cardiovascular Diseases. 2013;(1):24-34. (In Russ.) https://doi.org/10.17802/2306-1278-2013-1-24-34

Просмотров: 194


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)